BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Cornerstone BioPharma, Inc. 

2000 Regency Parkway, Suite 255

Cary  North Carolina  27511  U.S.A.
Phone: 888-466-6503 or 888-466-6503 Fax:


SEARCH JOBS

View Clinical Trials from BioPharm Insight

Cornerstone BioPharma, Inc., located next to North Carolina’s Research Triangle Park, is an emerging specialty pharmaceutical company that is currently focused on the development and commercialization of niche prescription medications in the pain, anti-infective, and respiratory markets. The privately held company owns the rights to a pain product line, three respiratory product lines, and co-promotes the Suprax® antibiotic. Cornerstone is actively engaged in the licensing of additional prescription products in niche markets through acquisitions and strategic partnerships.

For more information, please visit: www.cornerstonebiopharama.com

Last Updated: 03-14-05



 Key Statistics


Email: contact@cornerstonebiopharma.com
Ownership: Private

Web Site: Cornerstone BioPharma, Inc.
Employees:
Symbol: 
 









 Company News
Stipulation of Dismissal of Claims by Plaintiff Cornerstone BioPharma, Inc. 7/11/2013 9:57:47 AM    More...
Cornerstone BioPharma, Inc. Announces Completion of Merger with Critical Therapeutics 11/3/2008 9:47:52 AM    More...
Critical Therapeutics, Inc. (CRTX) Announces Stockholder Approvals Related to Merger with Cornerstone BioPharma, Inc. and 10-to-1 Reverse Stock Split 10/31/2008 11:16:58 AM    More...
Critical Therapeutics, Inc. (CRTX) Announces Effectiveness Of Registration Statement For The Proposed Merger With Cornerstone BioPharma, Inc. 10/6/2008 10:53:23 AM    More...
Cornerstone BioPharma, Inc. Welcomes David Price as CFO Price to Help Lead Company Through Transition, Growth 8/21/2008 8:36:49 AM    More...
Critical Therapeutics, Inc. (CRTX) Signs Definitive Agreement to Merge with Cornerstone BioPharma, Inc. 5/2/2008 9:55:27 AM    More...
Lupin Ltd. (LUPN.BO) And Cornerstone BioPharma, Inc. End Drug Deal 12/27/2006 10:52:44 AM    More...
Cornerstone BioPharma, Inc. Appoints Alastair McEwan As CFO 10/19/2005 5:12:58 PM    More...
Cornerstone BioPharma, Inc. Names Agencies Of Record 10/19/2005 5:12:54 PM    More...
Cornerstone BioPharma, Inc. And Adams Laboratories, Inc. Enter Product Transfer Agreement 10/19/2005 5:12:44 PM    More...
123